USA India Chamber of commerce

Chair and Master of Ceremonies (Emcee)– Dr. Andrew Plump, President of R&D, Takeda Pharmaceuticals

Timings are Eastern Standard Time (EST)

Time	Topic
8 AM - 8-10 AM	Welcome address: Karun Rishi, President, USAIC Opening comments: Dr Andrew Plump, President of R&D, Takeda Pharmaceuticals
8-10 AM - 8-50 AM	Panel Discussion- COVID-19: Where are we now? Where are we going? Panelists: Dr. Barry Bloom, Professor & former Dean, Harvard School of Public Health Dr. George Yancopoulos, Co-Founder, President & CSO, Regeneron Kiran Mazumdar-Shaw, Executive Chairperson, Biocon Dr. Rajeev Venkayya, President of the Global Vaccine Business Unit, Takeda Dr. Richard Hatchett, CEO, Coalition for Epidemic Preparedness Innovations (CEPI) Moderator: Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School
8-50 AM - 8-55 AM	Polling + Break
8-55 AM - 9-10 AM	India Regulatory update Dr. Mandeep Bhandari, Joint Secretary, Ministry of Health & Family Welfare, India Dr. V G Somani, Drug Controller General of India, Central Drug Control Organization Moderator: Muna Bhanji, Senior Vice President, Merck & Co.
9-10 AM - 9-15 AM	Polling + Break
9-15 AM - 9-55 AM	Fireside Chat Kenneth Frazier, Chairman of the Board and Chief Executive Officer, Merck & Co. Moderator: Dr. Stelios Papadopoulos, Chairman of the Board, Biogen
9-55 AM - 10 AM	Polling + Break
10 AM - 10-40 AM	India Innovation Landscape Panelists: Amitabh Kant, Chief Executive Officer, National Institution for Transforming India (NITI) Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group Dr. K. Vijay Raghavan, Principal Scientific Advisor, Government of India Dr. Naresh Trehan, Chairman, Medanta - the Medicity Moderator: Sanat Chattopadhyay, President, Merck Manufacturing Division; Merck & Co.
10-40 AM - 10-45 AM	Polling + Break
10-45 AM - 11-25 AM	Panel Discussion- Oncology: Changing landscape- COVID learnings and the promise of new technologies Panelists: Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic Dr. Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute Dr. Philip Larsen, Global Head of Research, Bayer AG Rehan Verjee, President, EMD Serono Dr. Tony Ho, Head of Research and Development, CRISPR Therapeutics Moderator: Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School
11-25 AM - 11-30 AM	Polling + Break
11-30 AM - 12-10 PM	Panel Discussion- Industry & Investment Outlook Panelists: Christopher Viehbacher, Managing Partner, Gurnet Point Capital Daphne Zohar, Founder & CEO, PureTech Health Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University Dr. Stelios Papadopoulos, Chairman, Biogen Moderator: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals
12-10 PM - 12-20 PM	Polling + Break
12-20 PM - 1 PM	Panel Discussion- Rare Diseases: No longer forgotten; but more to be achieved Panelists: Dr. Alfred Sandrock, Executive Vice President, Research & Development, Biogen Dr. Daniel Curran, Head of the Rare Diseases Therapeutic Area Unit, Takeda Dr. David Meeker, Chairman & CEO , Rhythm Pharmaceuticals Dr. John Orloff, Head of Research & Development, Alexion Matt Wilsey, Co-Founder & Chairman, Grace Science Foundation Moderator: Dr. Steve Uden, Co-Founder, Rallybio
1 PM - 1-05 PM	Polling + Break
1-05 PM - 1-50 PM	Fireside Chat Dr. Roy Vagelos, Chairman of the Board, Regeneron Pharmaceuticals Moderator: Dr. Mathai Mammen, Global Head of Janssen Research & Development, Johnson & Johnson
1-50 PM - 1-55 PM	Polling + Break
1-55 PM - 2-35 PM	Panel Discussion- Digital & Data Science in Healthcare: Pragmatic Insights from the Real-World Panelists: Dr. Anne Heatherington, Head of Data Sciences Institute, Takeda Pharmaceuticals Arpa Garay, President, Global Pharmaceuticals, Commercial Analytics, Merck & Co. Dr. Maya Said, Chief Executive Officer, Outcomes4Me Dr. Najat Khan, Chief Operating Officer, Janssen R&D Data Sciences, Johnson & Johnson Nina Kjellson, General Partner, Canaan Moderator: Sastry Chilukuri, President, Acorn AI- Medidata
2-35 PM - 2-40 PM	Polling + Break
2-40 PM - 3-20 PM	Panel Discussion- R&D Strategies and Trends: Innovation- The Big I Panelists: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals Dr. David Reese, Executive Vice President, Research and Development, Amgen Dr. Hal Barron, Chief Scientific Officer and President R&D, GlaxoSmithKline Dr. Mathai Mammen, Global Head of Janssen Research & Development, Johnson & Johnson Moderator: Dr. Martin Mackay, Co-Founder, Rallybio
3-20 PM - 3-30 PM	Closing Remarks

*Speaker and Timings subject to change